The deal makes MJH the largest privately held medical media company in the U.S.
Serving up health content that appeals to younger users helped fuel Healthline’s traffic surge. But is the same formula enough to push it past WebMD?
The third annual list of healthcare industry heavyweights assembled by the editors of MM&M and PRWeek—the Health Influencer 50—has made its debut.
For many online health communities, the Facebook-Cambridge Analytica scandal didn’t have a significant impact, and members still see the social network as an invaluable resource.
For Gideon, honoring those who helped build the medical ad industry became a labor of love.
A longtime colleague remembers his indelible imprint.
The channel will feature content about the full range of the cancer journey.
Facebook sought to blame GDPR as it revealed its daily active users in Europe declined for the first time in nine years and it disappointed investors with lower-than-expected growth.
Some Twitter accounts could lose millions of followers when the social platform purges large numbers of “locked” accounts this week.
Healthcare journalists and communicators have an obligation to facilitate informed conversation, not simply put out information. Does the Times’ take on a recent gene test live up to that standard?
The two organizations will partner on content including personal stories and expert advice.
In an effort to assure advertisers and agencies on brand safety, Google has announced two new requirements for video creators that intend to join the YouTube Partner Program.
Facebook’s decision to reprioritise its news feed to favour “social interactions” over other forms of content may please its users but will be challenging for brands.
Topping the list: The MM&M agency issue, the MM&M Awards winners and shortlist, and how a porn star is providing sex ed to seniors
The pharma unit of Johnson & Johnson launched the Cancer.com website this month.